Kezar Life Sciences Stock Performance
| KZR Stock | USD 6.70 0.06 0.89% |
Kezar Life has a performance score of 8 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.24, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Kezar Life's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kezar Life is expected to be smaller as well. Kezar Life Sciences right now secures a risk of 1.18%. Please verify Kezar Life Sciences treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to decide if Kezar Life Sciences will be following its current price movements.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Kezar Life Sciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Kezar Life may actually be approaching a critical reversion point that can send shares even higher in April 2026. ...more
Actual Historical Performance (%)
Five Day Return (2.33) | Year To Date Return 6.52 | Ten Year Return (99.62) | All Time Return (99.62) |
Last Split Factor 1:10 | Last Split Date 2024-10-30 |
1 | How Kezar Life Sciences Inc. stock trades pre earnings - Analyst Downgrade Community Consensus Trade Signals - DonanmHaber | 12/19/2025 |
2 | Favourable Signals For Kalamazoo Resources Numerous Insiders Acquired Stock | 12/29/2025 |
3 | What Kalamazoos New Share Quotation Means for ASX Mining | 01/07/2026 |
4 | Capital Support Drives Kalamazoos Exploration Momentum | 01/12/2026 |
5 | Kalamazoo Drives Mt Olympus Forward with Study and Drilling Push | 01/15/2026 |
6 | Central Victorian gold-antimony corridor takes shape for Kalamazoo. | 02/12/2026 |
7 | Will Kezar Life Sciences Inc. stock recover faster than peers - Product Launch Technical Confirmation Alerts - mfd.ru | 02/20/2026 |
| Begin Period Cash Flow | 35.5 M | |
| Total Cashflows From Investing Activities | 80.4 M |
Kezar Life Relative Risk vs. Return Landscape
If you would invest 622.00 in Kezar Life Sciences on December 1, 2025 and sell it today you would earn a total of 48.00 from holding Kezar Life Sciences or generate 7.72% return on investment over 90 days. Kezar Life Sciences is generating 0.1268% of daily returns assuming volatility of 1.1797% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Kezar, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Kezar Life Target Price Odds to finish over Current Price
The tendency of Kezar Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 6.70 | 90 days | 6.70 | about 1.14 |
Based on a normal probability distribution, the odds of Kezar Life to move above the current price in 90 days from now is about 1.14 (This Kezar Life Sciences probability density function shows the probability of Kezar Stock to fall within a particular range of prices over 90 days) .
Kezar Life Price Density |
| Price |
Predictive Modules for Kezar Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kezar Life Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Kezar Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Kezar Life is not an exception. The market had few large corrections towards the Kezar Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Kezar Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Kezar Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 0.24 | |
σ | Overall volatility | 0.18 | |
Ir | Information ratio | 0.02 |
Kezar Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Kezar Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Kezar Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Kezar Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (83.74 M) with loss before taxes, overhead, and interest of (44.71 M). | |
| Kezar Life Sciences has about 306.84 M in cash with (74.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49. | |
| Kezar Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 62.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Will Kezar Life Sciences Inc. stock recover faster than peers - Product Launch Technical Confirmation Alerts - mfd.ru |
Kezar Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Kezar Stock often depends not only on the future outlook of the current and potential Kezar Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kezar Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 72.9 M | |
| Cash And Short Term Investments | 132.2 M |
Kezar Life Fundamentals Growth
Kezar Stock prices reflect investors' perceptions of the future prospects and financial health of Kezar Life, and Kezar Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kezar Stock performance.
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | (31.24 M) | ||||
| Shares Outstanding | 7.32 M | ||||
| Price To Earning | (9.34) X | ||||
| Price To Book | 0.59 X | ||||
| Price To Sales | 6.03 X | ||||
| Gross Profit | (44.71 M) | ||||
| EBITDA | (81.1 M) | ||||
| Net Income | (83.74 M) | ||||
| Cash And Equivalents | 306.84 M | ||||
| Cash Per Share | 4.49 X | ||||
| Total Debt | 16.18 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 39.64 X | ||||
| Book Value Per Share | 11.33 X | ||||
| Cash Flow From Operations | (74.21 M) | ||||
| Earnings Per Share | (8.44) X | ||||
| Market Capitalization | 49.07 M | ||||
| Total Asset | 144.68 M | ||||
| Retained Earnings | (434.5 M) | ||||
| Working Capital | 117.16 M | ||||
| Current Asset | 74.47 M | ||||
| Current Liabilities | 2.18 M | ||||
About Kezar Life Performance
Assessing Kezar Life's fundamental ratios provides investors with valuable insights into Kezar Life's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Kezar Life is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.52) | (0.55) | |
| Return On Capital Employed | (0.84) | (0.88) | |
| Return On Assets | (0.52) | (0.55) | |
| Return On Equity | (0.82) | (0.78) |
Things to note about Kezar Life Sciences performance evaluation
Checking the ongoing alerts about Kezar Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kezar Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kezar Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (83.74 M) with loss before taxes, overhead, and interest of (44.71 M). | |
| Kezar Life Sciences has about 306.84 M in cash with (74.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.49. | |
| Kezar Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 62.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Will Kezar Life Sciences Inc. stock recover faster than peers - Product Launch Technical Confirmation Alerts - mfd.ru |
- Analyzing Kezar Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kezar Life's stock is overvalued or undervalued compared to its peers.
- Examining Kezar Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kezar Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kezar Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kezar Life's stock. These opinions can provide insight into Kezar Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.